feed,title,long_url,short_url
Benzinga,"Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases",https://benzinga.com/news/22/08/28377654/biotech-daily-thumbs-down-for-acadias-antipsychotic-drug-akebia-fails-covid-19-study-kazias-encourag,https://bit.ly/3d8VZZr
Benzinga,Neurocrine Biosciences Shares Jump After Raising Ingrezza Sales Guidance,https://benzinga.com/general/biotech/22/08/28377619/neurocrine-biosciences-shares-jump-after-raising-ingrezza-sales-guidance,https://bit.ly/3PYF2PQ
